Skip to content
OPEN VARIABLE

Evidence-First Signal Intelligence

Menu

Research literature / Journal article

END-TO-END AUTOMATED MANUFACTURING OF AUTOLOGOUS CAR T CELL THERAPIES WITH THE NEW SEFIA™ CELL THERAPY MANUFACTURING PLATFORM

C. Farino Reyes; R. Jamal; M. Ryan; N. McKenzie; C. Mizzoni; S. Deshpande; Y. Liu; A. Maystrenko; D. Arab; M. Maggioni; P. Zotos; F. Zanoni; M. Parvizi; M. de Lageneste; F. Franchi

Published
Publisher
Elsevier BV
Journal / collection
Cytotherapy
Research area
Industrial systems
Source type
Journal article
DOI
10.1016/j.jcyt.2024.03.325

Read the original source ↗

The original publisher provides the full text and its access options.

Cite this source

C. Farino Reyes; R. Jamal; M. Ryan; N. McKenzie; C. Mizzoni; S. Deshpande; Y. Liu; A. Maystrenko; D. Arab; M. Maggioni; P. Zotos; F. Zanoni; M. Parvizi; M. de Lageneste; F. Franchi. END-TO-END AUTOMATED MANUFACTURING OF AUTOLOGOUS CAR T CELL THERAPIES WITH THE NEW SEFIA™ CELL THERAPY MANUFACTURING PLATFORM. Cytotherapy. 2024-06. https://doi.org/10.1016/j.jcyt.2024.03.325

Download RIS